Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This phase II trial studies how well pembrolizumab works in treating patients with stage IB-IVB mycosis fungoides or Sezary syndrome that has returned after a period of improvement or has not responded to at least one type of treatment. Monoclonal antibodies, such as pembrolizumab, may block cancer growth in different ways by targeting certain cells.
Epistemonikos ID: 39dec1eb5aa3adf4a7fb65046b65ac260075ed46
First added on: May 12, 2024